Cerenome (PSTV) Prepaid Assets (2010 - 2026)
Plus Therapeutics (PSTV) posted quarterly Prepaid Assets of $1.6 million for Q1 2026, up 56.24% year-over-year from $1.0 million in Q1 2025, and up 96.24% quarter-over-quarter from $797000.0 in Q4 2025.
Cerenome (PSTV) Prepaid Assets (2010 - 2026) Analysis & Trends
Plus Therapeutics (PSTV) has reported Prepaid Assets for 17 consecutive years, with $1.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Prepaid Assets rose 56.24% year-over-year to $1.6 million; the TTM figure through Mar 2026 stood at $1.6 million (up 56.24% YoY), while the FY2025 annual figure was $797000.0, up 42.58% from the prior year.
- Prepaid Assets advanced to $1.6 million in Q1 2026 per PSTV's latest filing, from $797000.0 in the prior quarter.
- Across five years, Prepaid Assets topped out at $1.6 million in Q1 2026 and bottomed at $487000.0 in Q3 2023.
- Historically, Prepaid Assets has averaged $860117.6 across 5 years, with a median of $799000.0 in 2022.
- Annual changes were most pronounced in 2023 — Prepaid Assets jumped 83.38% — and 2024, when it sank 56.33%.
- Plus Therapeutics' Prepaid Assets stood at $698000.0 in 2022, then soared by 83.38% to $1.3 million in 2023, then tumbled by 56.33% to $559000.0 in 2024, then jumped by 42.58% to $797000.0 in 2025, then soared by 96.24% to $1.6 million in 2026.
- Business Quant data shows PSTV's Prepaid Assets at $1.6 million in Q1 2026, $797000.0 in Q4 2025, and $551000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Cerenome | 28.07 Mn | 19.48 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.56 Mn |
| Dec 31, 2025 | 797,000.00 |
| Sep 30, 2025 | 551,000.00 |
| Jun 30, 2025 | 1.31 Mn |
| Mar 31, 2025 | 1.00 Mn |
| Dec 31, 2024 | 559,000.00 |
| Sep 30, 2024 | 576,000.00 |
| Jun 30, 2024 | 945,000.00 |
| Mar 31, 2024 | 989,000.00 |
| Dec 31, 2023 | 1.28 Mn |
| Sep 30, 2023 | 487,000.00 |
| Jun 30, 2023 | 751,000.00 |
| Mar 31, 2023 | 906,000.00 |
| Dec 31, 2022 | 698,000.00 |
| Sep 30, 2022 | 540,000.00 |
| Jun 30, 2022 | 799,000.00 |
| Mar 31, 2022 | 865,000.00 |
| Dec 31, 2021 | 1.32 Mn |
| Sep 30, 2021 | 817,000.00 |
| Jun 30, 2021 | 840,000.00 |